JENAFER HAMMOND: Open Payments
NPI 1942247309 · WARREN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$444 in 25 payments from 9 companies in 2025. Trend: 2023 $889 · 2024 $1,022 · 2025 $444
Food & beverage: $444
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $84 |
| Novo Nordisk Inc | 4 | $74 |
| Exact Sciences Corporation | 3 | $64 |
| Lilly USA, LLC | 3 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49 |
| ABBVIE INC. | 3 | $48 |
| PFIZER INC. | 2 | $34 |
| Abbott Laboratories | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: Cologuard Collection Kit, MOUNJARO, Ozempic, AIRSUPRA, Kerendia, QULIPTA, Wegovy, FREESTYLE LIBRE 3.
Industry payments across PA — which companies pay providers there.
